In conclusion, DUBR/miR-502-3p/GPX3 may be a potential regulatory pathway for normal gastric epithelium mucosa transforms into GC and tumor progression, which activates at different stages of tumor development to inhibit or promote cancer. The gene discussed is DUBR; the disease is cancer.